Medical News

Kisspeptin and its receptor GPR54 predict a favourable clinical outcome in women with ovarian carcinoma, and are specific for the clear cell carcinoma subtype, research published this week in the online open access journal, BMC Medicine, reveals. The kisspeptins, a family of peptide hormones, and the receptor GPR54 have previously been linked to anti-metastatic activity in certain human tumours. In this study, scientists have shown that kisspeptin and GPR54 are independent prognostic biomarkers specific for ovarian clear cell carcinoma - the first such markers to be identified……..

Original post by Health news from medicineworld.org

Kisspeptin and its receptor GPR54 predict a favourable clinical outcome in women with ovarian carcinoma, and are specific for the clear cell carcinoma subtype, research published this week in the online open access journal, BMC Medicine, reveals. The kisspeptins, a family of peptide hormones, and the receptor GPR54 have previously been linked to anti-metastatic activity in certain human tumours. In this study, scientists have shown that kisspeptin and GPR54 are independent prognostic biomarkers specific for ovarian clear cell carcinoma - the first such markers to be identified……..

Original post by Health news from medicineworld.org